Masoval AS

As of June 30, 2026, Masoval AS carries a market capitalization of 3.98B, placing it among publicly traded companies globally. Its enterprise value stands at 5.97B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Masoval AS's next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2026, Masoval AS has 122.51M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.44, and the price-to-book ratio stands at 2.32.

As of June 30, 2026, Masoval AS trades at an EV/EBITDA multiple of 39.33 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.16 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 5.97B versus a market cap of 3.98B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Masoval AS maintains a current ratio of 1.00, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 122.56, indicating elevated leverage, while an interest coverage ratio of 0.92 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Masoval AS posted a negative return on equity (ROE) of -7.47, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -2.66, reflecting losses generated across the asset base. The company generates approximately 7.90M in revenue per employee across its workforce of 349.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.72 indicates how many times Masoval AS sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Masoval AS recorded an income tax benefit of -161.23M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -297.50M and -131.98M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Masoval AS's stock has gained approximately 53.85% over the past 52 weeks. The 50-day moving average sits at 37.87, while the 200-day moving average is 31.99.

Over the twelve months ended June 30, 2026, Masoval AS generated 2.76B in revenue and converted that into -131.98M in net income, yielding earnings per share of -1.11. EBITDA reached 151.77M, while operating income came in at -128.52M.

As of June 30, 2026, Masoval AS holds 114.17M in cash and equivalents against 2.10B in total debt, resulting in a net debt position of 1.42B. Total book value stands at 1.72B, with working capital of 1.96M providing operational flexibility.

Masoval AS produced 607.40M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -93.51M in capital expenditures, free cash flow totaled 513.90M - equivalent to 4.20 per share.

Over the twelve months ended June 30, 2026, Masoval AS posted a gross margin of 41.80, reflecting its pricing power and cost economics. The operating margin of -4.65 and net profit margin of -4.78 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 12.91, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 13.43, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Masoval AS shareholders.